APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pemetrexed Diacid

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Pemetrexed Diacid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025197 pages

Choose your research edition.

Industry ResearchPemetrexed Diacid Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Pemetrexed Diacid Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Pemetrexed Diacid Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pemetrexed Diacid Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Pemetrexed Diacid Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Pemetrexed Diacid market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Pemetrexed Diacid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pemetrexed Diacid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pemetrexed Diacid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Pemetrexed Diacid is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Pemetrexed Diacid include Qilu Pharma, Nanjing Pharmaceutical Factory Co., Ltd., Lianyungang Tengfa Bio-tech Co., Ltd., Eli Lilly and Company, United Biotech India Pvt.Ltd., Pemgem, Onkos, Natco Pharma Ltd and Emcure, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Pemetrexed Diacid market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pemetrexed Diacid and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pemetrexed Diacid sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pemetrexed Diacid market size, projected growth trends, production technologies, key applications, and end-use industries.

Pemetrexed Diacid Segment by Company

Qilu Pharma

Nanjing Pharmaceutical Factory Co., Ltd.

Lianyungang Tengfa Bio-tech Co., Ltd.

Eli Lilly and Company

United Biotech India Pvt.Ltd.

Pemgem

Onkos

Natco Pharma Ltd

Emcure

Cytotoxic

ChemOthersapy

Beacon Pharma

Actiza Parma

Pemetrexed Diacid Segment by Type

500mg Injection

300mg Injection

200mg Injection

100mg Injection

Pemetrexed Diacid Segment by Application

Mesothelioma

Non-Small Cell Lung Cancer

Others

Pemetrexed Diacid Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pemetrexed Diacid market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pemetrexed Diacid and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pemetrexed Diacid.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pemetrexed Diacid market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Pemetrexed Diacid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Pemetrexed Diacid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Pemetrexed Diacid in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Pemetrexed Diacid Industry Trends Table 2. Pemetrexed Diacid Industry Drivers Table 3. Pemetrexed Diacid Industry Opportunities and Challenges Table 4. Pemetrexed Diacid Industry Restraints Table 5. Global Pemetrexed Diacid Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Pemetrexed Diacid Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Pemetrexed Diacid Sales by Manufacturers (doses) & (2021-2026) Table 8. Global Pemetrexed Diacid Sales Market Share by Manufacturers Table 9. Global Pemetrexed Diacid Average Sales Price (US$/dose) of Manufacturers (2021-2026) Table 10. Global Pemetrexed Diacid Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Pemetrexed Diacid Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Pemetrexed Diacid Manufacturers, Product Type & Application Table 13. Global Pemetrexed Diacid Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Pemetrexed Diacid by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 500mg Injection Table 17. Major Manufacturers of 300mg Injection Table 18. Major Manufacturers of 200mg Injection Table 19. Major Manufacturers of 100mg Injection Table 20. Global Pemetrexed Diacid Sales by Type 2021 VS 2025 VS 2032 (doses) Table 21. Global Pemetrexed Diacid Sales by Type (2021-2026) & (doses) Table 22. Global Pemetrexed Diacid Sales by Type (2027-2032) & (doses) Table 23. Global Pemetrexed Diacid Sales Market Share by Type (2021-2026) Table 24. Global Pemetrexed Diacid Sales Market Share by Type (2027-2032) Table 25. Global Pemetrexed Diacid Revenue by Type 2021 VS 2025 VS 2032 (doses) Table 26. Global Pemetrexed Diacid Revenue by Type (2021-2026) & (doses) Table 27. Global Pemetrexed Diacid Revenue by Type (2027-2032) & (doses) Table 28. Global Pemetrexed Diacid Revenue Market Share by Type (2021-2026) Table 29. Global Pemetrexed Diacid Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Mesothelioma Table 31. Major Manufacturers of Non-Small Cell Lung Cancer Table 32. Major Manufacturers of Others Table 33. Global Pemetrexed Diacid Sales by Application 2021 VS 2025 VS 2032 (doses) Table 34. Global Pemetrexed Diacid Sales by Application (2021-2026) & (doses) Table 35. Global Pemetrexed Diacid Sales by Application (2027-2032) & (doses) Table 36. Global Pemetrexed Diacid Sales Market Share by Application (2021-2026) Table 37. Global Pemetrexed Diacid Sales Market Share by Application (2027-2032) Table 38. Global Pemetrexed Diacid Revenue by Application 2021 VS 2025 VS 2032 (doses) Table 39. Global Pemetrexed Diacid Revenue by Application (2021-2026) & (doses) Table 40. Global Pemetrexed Diacid Revenue by Application (2027-2032) & (doses) Table 41. Global Pemetrexed Diacid Revenue Market Share by Application (2021-2026) Table 42. Global Pemetrexed Diacid Revenue Market Share by Application (2027-2032) Table 43. Global Pemetrexed Diacid Sales by Region: 2021 VS 2025 VS 2032 (doses) Table 44. Global Pemetrexed Diacid Sales by Region (2021-2026) & (doses) Table 45. Global Pemetrexed Diacid Sales Market Share by Region (2021-2026) Table 46. Global Pemetrexed Diacid Sales Forecasted by Region (2027-2032) & (doses) Table 47. Global Pemetrexed Diacid Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Pemetrexed Diacid Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (doses) Table 49. North America Pemetrexed Diacid Sales by Country (2021-2026) & (doses) Table 50. North America Pemetrexed Diacid Sales by Country (2027-2032) & (doses) Table 51. Europe Pemetrexed Diacid Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (doses) Table 52. Europe Pemetrexed Diacid Sales by Country (2021-2026) & (doses) Table 53. Europe Pemetrexed Diacid Sales by Country (2027-2032) & (doses) Table 54. Asia Pacific Pemetrexed Diacid Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (doses) Table 55. Asia Pacific Pemetrexed Diacid Sales by Country (2021-2026) & (doses) Table 56. Asia Pacific Pemetrexed Diacid Sales by Country (2027-2032) & (doses) Table 57. South America, Middle East and Africa Pemetrexed Diacid Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (doses) Table 58. South America, Middle East and Africa Pemetrexed Diacid Sales by Country (2021-2026) & (doses) Table 59. South America, Middle East and Africa Pemetrexed Diacid Sales by Country (2027-2032) & (doses) Table 60. Global Pemetrexed Diacid Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Pemetrexed Diacid Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Pemetrexed Diacid Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Pemetrexed Diacid Revenue Market Share by Region (2021-2026) Table 64. Global Pemetrexed Diacid Revenue Market Share by Region (2027-2032) Table 65. Qilu Pharma Company Information Table 66. Qilu Pharma Business Overview Table 67. Qilu Pharma Pemetrexed Diacid Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Qilu Pharma Pemetrexed Diacid Product Portfolio Table 69. Qilu Pharma Recent Development Table 70. Nanjing Pharmaceutical Factory Co., Ltd. Company Information Table 71. Nanjing Pharmaceutical Factory Co., Ltd. Business Overview Table 72. Nanjing Pharmaceutical Factory Co., Ltd. Pemetrexed Diacid Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Nanjing Pharmaceutical Factory Co., Ltd. Pemetrexed Diacid Product Portfolio Table 74. Nanjing Pharmaceutical Factory Co., Ltd. Recent Development Table 75. Lianyungang Tengfa Bio-tech Co., Ltd. Company Information Table 76. Lianyungang Tengfa Bio-tech Co., Ltd. Business Overview Table 77. Lianyungang Tengfa Bio-tech Co., Ltd. Pemetrexed Diacid Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Lianyungang Tengfa Bio-tech Co., Ltd. Pemetrexed Diacid Product Portfolio Table 79. Lianyungang Tengfa Bio-tech Co., Ltd. Recent Development Table 80. Eli Lilly and Company Company Information Table 81. Eli Lilly and Company Business Overview Table 82. Eli Lilly and Company Pemetrexed Diacid Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Eli Lilly and Company Pemetrexed Diacid Product Portfolio Table 84. Eli Lilly and Company Recent Development Table 85. United Biotech India Pvt.Ltd. Company Information Table 86. United Biotech India Pvt.Ltd. Business Overview Table 87. United Biotech India Pvt.Ltd. Pemetrexed Diacid Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. United Biotech India Pvt.Ltd. Pemetrexed Diacid Product Portfolio Table 89. United Biotech India Pvt.Ltd. Recent Development Table 90. Pemgem Company Information Table 91. Pemgem Business Overview Table 92. Pemgem Pemetrexed Diacid Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Pemgem Pemetrexed Diacid Product Portfolio Table 94. Pemgem Recent Development Table 95. Onkos Company Information Table 96. Onkos Business Overview Table 97. Onkos Pemetrexed Diacid Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Onkos Pemetrexed Diacid Product Portfolio Table 99. Onkos Recent Development Table 100. Natco Pharma Ltd Company Information Table 101. Natco Pharma Ltd Business Overview Table 102. Natco Pharma Ltd Pemetrexed Diacid Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Natco Pharma Ltd Pemetrexed Diacid Product Portfolio Table 104. Natco Pharma Ltd Recent Development Table 105. Emcure Company Information Table 106. Emcure Business Overview Table 107. Emcure Pemetrexed Diacid Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Emcure Pemetrexed Diacid Product Portfolio Table 109. Emcure Recent Development Table 110. Cytotoxic Company Information Table 111. Cytotoxic Business Overview Table 112. Cytotoxic Pemetrexed Diacid Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Cytotoxic Pemetrexed Diacid Product Portfolio Table 114. Cytotoxic Recent Development Table 115. ChemOthersapy Company Information Table 116. ChemOthersapy Business Overview Table 117. ChemOthersapy Pemetrexed Diacid Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. ChemOthersapy Pemetrexed Diacid Product Portfolio Table 119. ChemOthersapy Recent Development Table 120. Beacon Pharma Company Information Table 121. Beacon Pharma Business Overview Table 122. Beacon Pharma Pemetrexed Diacid Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Beacon Pharma Pemetrexed Diacid Product Portfolio Table 124. Beacon Pharma Recent Development Table 125. Actiza Parma Company Information Table 126. Actiza Parma Business Overview Table 127. Actiza Parma Pemetrexed Diacid Sales (doses), Price (US$/dose), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Actiza Parma Pemetrexed Diacid Product Portfolio Table 129. Actiza Parma Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Pemetrexed Diacid Distributors List Table 133. Pemetrexed Diacid Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Pemetrexed Diacid Product Image Figure 2. Global Pemetrexed Diacid Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pemetrexed Diacid Market Size (2021-2032) & (US$ Million) Figure 4. Global Pemetrexed Diacid Sales (2021-2032) & (doses) Figure 5. Global Pemetrexed Diacid Average Price (US$/dose) & (2021-2032) Figure 6. Global Top 5 and 10 Pemetrexed Diacid Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 500mg Injection Image Figure 9. 300mg Injection Image Figure 10. 200mg Injection Image Figure 11. 100mg Injection Image Figure 12. Global Pemetrexed Diacid Sales by Type (2021 VS 2025 VS 2032) & (doses) Figure 13. Global Pemetrexed Diacid Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Pemetrexed Diacid Sales Market Share by Type (2021-2032) Figure 15. Global Pemetrexed Diacid Revenue by Type (2021 VS 2025 VS 2032) & (doses) Figure 16. Global Pemetrexed Diacid Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Pemetrexed Diacid Revenue Market Share by Type (2021-2032) Figure 18. Mesothelioma Image Figure 19. Non-Small Cell Lung Cancer Image Figure 20. Others Image Figure 21. Global Pemetrexed Diacid Sales by Application (2021 VS 2025 VS 2032) & (doses) Figure 22. Global Pemetrexed Diacid Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Pemetrexed Diacid Sales Market Share by Application (2021-2032) Figure 24. Global Pemetrexed Diacid Revenue by Application (2021 VS 2025 VS 2032) & (doses) Figure 25. Global Pemetrexed Diacid Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Pemetrexed Diacid Revenue Market Share by Application (2021-2032) Figure 27. North America Pemetrexed Diacid Sales and Growth Rate (2021-2032) & (doses) Figure 28. North America Pemetrexed Diacid Sales Market Share by Country (2021-2032) Figure 29. U.S. Pemetrexed Diacid Sales and Growth Rate (2021-2032) & (doses) Figure 30. Canada Pemetrexed Diacid Sales and Growth Rate (2021-2032) & (doses) Figure 31. Mexico Pemetrexed Diacid Sales and Growth Rate (2021-2032) & (doses) Figure 32. Europe Pemetrexed Diacid Sales and Growth Rate (2021-2032) & (doses) Figure 33. Europe Pemetrexed Diacid Sales Market Share by Country (2021-2032) Figure 34. Germany Pemetrexed Diacid Sales and Growth Rate (2021-2032) & (doses) Figure 35. France Pemetrexed Diacid Sales and Growth Rate (2021-2032) & (doses) Figure 36. U.K. Pemetrexed Diacid Sales and Growth Rate (2021-2032) & (doses) Figure 37. Italy Pemetrexed Diacid Sales and Growth Rate (2021-2032) & (doses) Figure 38. Netherlands Pemetrexed Diacid Sales and Growth Rate (2021-2032) & (doses) Figure 39. Asia Pacific Pemetrexed Diacid Sales and Growth Rate (2021-2032) & (doses) Figure 40. Asia Pacific Pemetrexed Diacid Sales Market Share by Country (2021-2032) Figure 41. China Pemetrexed Diacid Sales and Growth Rate (2021-2032) & (doses) Figure 42. Japan Pemetrexed Diacid Sales and Growth Rate (2021-2032) & (doses) Figure 43. South Korea Pemetrexed Diacid Sales and Growth Rate (2021-2032) & (doses) Figure 44. Southeast Asia Pemetrexed Diacid Sales and Growth Rate (2021-2032) & (doses) Figure 45. India Pemetrexed Diacid Sales and Growth Rate (2021-2032) & (doses) Figure 46. Australia Pemetrexed Diacid Sales and Growth Rate (2021-2032) & (doses) Figure 47. South America, Middle East and Africa Pemetrexed Diacid Sales and Growth Rate (2021-2032) & (doses) Figure 48. South America, Middle East and Africa Pemetrexed Diacid Sales Market Share by Country (2021-2032) Figure 49. Brazil Pemetrexed Diacid Sales and Growth Rate (2021-2032) & (doses) Figure 50. South Africa Pemetrexed Diacid Sales and Growth Rate (2021-2032) & (doses) Figure 51. Saudi Arabia Pemetrexed Diacid Sales and Growth Rate (2021-2032) & (doses) Figure 52. Turkey Pemetrexed Diacid Sales and Growth Rate (2021-2032) & (doses) Figure 53. Argentina Pemetrexed Diacid Sales and Growth Rate (2021-2032) & (doses) Figure 54. UAE Pemetrexed Diacid Sales and Growth Rate (2021-2032) & (doses) Figure 55. Egypt Pemetrexed Diacid Sales and Growth Rate (2021-2032) & (doses) Figure 56. Chile Pemetrexed Diacid Sales and Growth Rate (2021-2032) & (doses) Figure 57. Global Pemetrexed Diacid Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Pemetrexed Diacid Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Figure 60. North America Pemetrexed Diacid Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Figure 62. Europe Pemetrexed Diacid Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Pemetrexed Diacid Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Pemetrexed Diacid Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Pemetrexed Diacid Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Pemetrexed Diacid Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Pemetrexed Diacid Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 500mg Injection
  • 300mg Injection
  • 200mg Injection
  • 100mg Injection
Applications
  • Mesothelioma
  • Non-Small Cell Lung Cancer
  • Others
Companies covered
  • Qilu Pharma
  • Nanjing Pharmaceutical Factory Co., Ltd.
  • Lianyungang Tengfa Bio-tech Co., Ltd.
  • Eli Lilly and Company
  • United Biotech India Pvt.Ltd.
  • Pemgem
  • Onkos
  • Natco Pharma Ltd
  • Emcure
  • Cytotoxic
  • ChemOthersapy
  • Beacon Pharma
  • Actiza Parma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pemetrexed Diacid Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pemetrexed Diacid Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Pemetrexed Diacid Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Pemetrexed Diacid Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Pemetrexed Diacid Market Dynamics
  1. 2.1 Pemetrexed Diacid Industry Trends
  2. 2.2 Pemetrexed Diacid Industry Drivers
  3. 2.3 Pemetrexed Diacid Industry Opportunities and Challenges
  4. 2.4 Pemetrexed Diacid Industry Restraints
3 Pemetrexed Diacid Market by Manufacturers
  1. 3.1 Global Pemetrexed Diacid Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Pemetrexed Diacid Sales by Manufacturers (2021-2026)
  3. 3.3 Global Pemetrexed Diacid Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Pemetrexed Diacid Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Pemetrexed Diacid Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Pemetrexed Diacid Manufacturers, Product Type & Application
  7. 3.7 Global Pemetrexed Diacid Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Pemetrexed Diacid Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Pemetrexed Diacid Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Pemetrexed Diacid Tier 1, Tier 2, and Tier 3
4 Pemetrexed Diacid Market by Type
  1. 4.1 Pemetrexed Diacid Type Introduction
  2. 4.1.1 500mg Injection
  3. 4.1.2 300mg Injection
  4. 4.1.3 200mg Injection
  5. 4.1.4 100mg Injection
  6. 4.2 Global Pemetrexed Diacid Sales by Type
  7. 4.2.1 Global Pemetrexed Diacid Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pemetrexed Diacid Sales by Type (2021-2032)
  9. 4.2.3 Global Pemetrexed Diacid Sales Market Share by Type (2021-2032)
  10. 4.3 Global Pemetrexed Diacid Revenue by Type
  11. 4.3.1 Global Pemetrexed Diacid Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Pemetrexed Diacid Revenue by Type (2021-2032)
  13. 4.3.3 Global Pemetrexed Diacid Revenue Market Share by Type (2021-2032)
5 Pemetrexed Diacid Market by Application
  1. 5.1 Pemetrexed Diacid Application Introduction
  2. 5.1.1 Mesothelioma
  3. 5.1.2 Non-Small Cell Lung Cancer
  4. 5.1.3 Others
  5. 5.2 Global Pemetrexed Diacid Sales by Application
  6. 5.2.1 Global Pemetrexed Diacid Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pemetrexed Diacid Sales by Application (2021-2032)
  8. 5.2.3 Global Pemetrexed Diacid Sales Market Share by Application (2021-2032)
  9. 5.3 Global Pemetrexed Diacid Revenue by Application
  10. 5.3.1 Global Pemetrexed Diacid Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Pemetrexed Diacid Revenue by Application (2021-2032)
  12. 5.3.3 Global Pemetrexed Diacid Revenue Market Share by Application (2021-2032)
6 Global Pemetrexed Diacid Sales by Region
  1. 6.1 Global Pemetrexed Diacid Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pemetrexed Diacid Sales by Region (2021-2032)
  3. 6.2.1 Global Pemetrexed Diacid Sales by Region (2021-2026)
  4. 6.2.2 Global Pemetrexed Diacid Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pemetrexed Diacid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Pemetrexed Diacid Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Pemetrexed Diacid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Pemetrexed Diacid Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Pemetrexed Diacid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Pemetrexed Diacid Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Pemetrexed Diacid Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Pemetrexed Diacid Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Pemetrexed Diacid Revenue by Region
  1. 7.1 Global Pemetrexed Diacid Revenue by Region
  2. 7.1.1 Global Pemetrexed Diacid Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Pemetrexed Diacid Revenue by Region (2021-2026)
  4. 7.1.3 Global Pemetrexed Diacid Revenue by Region (2027-2032)
  5. 7.1.4 Global Pemetrexed Diacid Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Pemetrexed Diacid Revenue (2021-2032)
  8. 7.2.2 North America Pemetrexed Diacid Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Pemetrexed Diacid Revenue (2021-2032)
  11. 7.3.2 Europe Pemetrexed Diacid Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Pemetrexed Diacid Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Pemetrexed Diacid Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Pemetrexed Diacid Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Pemetrexed Diacid Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Qilu Pharma
  2. 8.1.1 Qilu Pharma Company Information
  3. 8.1.2 Qilu Pharma Business Overview
  4. 8.1.3 Qilu Pharma Pemetrexed Diacid Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Qilu Pharma Pemetrexed Diacid Product Portfolio
  6. 8.1.5 Qilu Pharma Recent Developments
  7. 8.2 Nanjing Pharmaceutical Factory Co., Ltd.
  8. 8.2.1 Nanjing Pharmaceutical Factory Co., Ltd. Company Information
  9. 8.2.2 Nanjing Pharmaceutical Factory Co., Ltd. Business Overview
  10. 8.2.3 Nanjing Pharmaceutical Factory Co., Ltd. Pemetrexed Diacid Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Nanjing Pharmaceutical Factory Co., Ltd. Pemetrexed Diacid Product Portfolio
  12. 8.2.5 Nanjing Pharmaceutical Factory Co., Ltd. Recent Developments
  13. 8.3 Lianyungang Tengfa Bio-tech Co., Ltd.
  14. 8.3.1 Lianyungang Tengfa Bio-tech Co., Ltd. Company Information
  15. 8.3.2 Lianyungang Tengfa Bio-tech Co., Ltd. Business Overview
  16. 8.3.3 Lianyungang Tengfa Bio-tech Co., Ltd. Pemetrexed Diacid Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Lianyungang Tengfa Bio-tech Co., Ltd. Pemetrexed Diacid Product Portfolio
  18. 8.3.5 Lianyungang Tengfa Bio-tech Co., Ltd. Recent Developments
  19. 8.4 Eli Lilly and Company
  20. 8.4.1 Eli Lilly and Company Company Information
  21. 8.4.2 Eli Lilly and Company Business Overview
  22. 8.4.3 Eli Lilly and Company Pemetrexed Diacid Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Eli Lilly and Company Pemetrexed Diacid Product Portfolio
  24. 8.4.5 Eli Lilly and Company Recent Developments
  25. 8.5 United Biotech India Pvt.Ltd.
  26. 8.5.1 United Biotech India Pvt.Ltd. Company Information
  27. 8.5.2 United Biotech India Pvt.Ltd. Business Overview
  28. 8.5.3 United Biotech India Pvt.Ltd. Pemetrexed Diacid Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 United Biotech India Pvt.Ltd. Pemetrexed Diacid Product Portfolio
  30. 8.5.5 United Biotech India Pvt.Ltd. Recent Developments
  31. 8.6 Pemgem
  32. 8.6.1 Pemgem Company Information
  33. 8.6.2 Pemgem Business Overview
  34. 8.6.3 Pemgem Pemetrexed Diacid Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pemgem Pemetrexed Diacid Product Portfolio
  36. 8.6.5 Pemgem Recent Developments
  37. 8.7 Onkos
  38. 8.7.1 Onkos Company Information
  39. 8.7.2 Onkos Business Overview
  40. 8.7.3 Onkos Pemetrexed Diacid Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Onkos Pemetrexed Diacid Product Portfolio
  42. 8.7.5 Onkos Recent Developments
  43. 8.8 Natco Pharma Ltd
  44. 8.8.1 Natco Pharma Ltd Company Information
  45. 8.8.2 Natco Pharma Ltd Business Overview
  46. 8.8.3 Natco Pharma Ltd Pemetrexed Diacid Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Natco Pharma Ltd Pemetrexed Diacid Product Portfolio
  48. 8.8.5 Natco Pharma Ltd Recent Developments
  49. 8.9 Emcure
  50. 8.9.1 Emcure Company Information
  51. 8.9.2 Emcure Business Overview
  52. 8.9.3 Emcure Pemetrexed Diacid Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Emcure Pemetrexed Diacid Product Portfolio
  54. 8.9.5 Emcure Recent Developments
  55. 8.10 Cytotoxic
  56. 8.10.1 Cytotoxic Company Information
  57. 8.10.2 Cytotoxic Business Overview
  58. 8.10.3 Cytotoxic Pemetrexed Diacid Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Cytotoxic Pemetrexed Diacid Product Portfolio
  60. 8.10.5 Cytotoxic Recent Developments
  61. 8.11 ChemOthersapy
  62. 8.11.1 ChemOthersapy Company Information
  63. 8.11.2 ChemOthersapy Business Overview
  64. 8.11.3 ChemOthersapy Pemetrexed Diacid Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 ChemOthersapy Pemetrexed Diacid Product Portfolio
  66. 8.11.5 ChemOthersapy Recent Developments
  67. 8.12 Beacon Pharma
  68. 8.12.1 Beacon Pharma Company Information
  69. 8.12.2 Beacon Pharma Business Overview
  70. 8.12.3 Beacon Pharma Pemetrexed Diacid Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Beacon Pharma Pemetrexed Diacid Product Portfolio
  72. 8.12.5 Beacon Pharma Recent Developments
  73. 8.13 Actiza Parma
  74. 8.13.1 Actiza Parma Company Information
  75. 8.13.2 Actiza Parma Business Overview
  76. 8.13.3 Actiza Parma Pemetrexed Diacid Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Actiza Parma Pemetrexed Diacid Product Portfolio
  78. 8.13.5 Actiza Parma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Pemetrexed Diacid Value Chain Analysis
  2. 9.1.1 Pemetrexed Diacid Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Pemetrexed Diacid Production Mode & Process
  6. 9.2 Pemetrexed Diacid Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Pemetrexed Diacid Distributors
  9. 9.2.3 Pemetrexed Diacid Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst